Home › Funds › Tetragon Partners GP Ltd › TECX
Tetragon Partners GP Ltd position in TECX
TECTONIC THERAPEUTIC INC · Health Care
Tetragon Partners GP Ltd reported holding 46,516 shares of TECX (TECTONIC THERAPEUTIC INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 0.26% of its reported portfolio and ranking #33 among its reported holdings. Tetragon Partners GP Ltd has disclosed TECX holdings in 5 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tetragon Partners GP Ltd's TECX position evolved
Tetragon Partners GP Ltd first disclosed a stake in TECX in Q1 2025 at 187,500 shares (US$3.3M). The position peaked in Q2 2025 at 228,832 shares, worth US$4.5M. Across 5 filings, Tetragon Partners GP Ltd increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 46,516 shares valued at US$1.6M — an increase of 8,928 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 187.50K | $3.32M | New |
| Q2 2025 | 228.83K | $4.55M | Add |
| Q3 2025 | 243.73K | $3.82M | Add |
| Q1 2026 | 37.59K | $1.16M | New |
| Q2 2026 | 46.52K | $1.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECX and 13F data
TECX (TECTONIC THERAPEUTIC INC) is a Health Care company. 54 other funds we track also report a position in TECX — the largest reported positions include TCG Crossover Management, LLC (US$41.4M), First Light Asset Management, LLC (US$27.5M), 5AM Venture Management, LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECX
- TCG Crossover Management, LLC 1.20M sh · $41.42M · Q2 2026
- First Light Asset Management, LLC 800.73K sh · $27.52M · Q2 2026
- 5AM Venture Management, LLC 606.66K sh · $20.85M · Q2 2026
- BRAIDWELL LP 596.90K sh · $20.52M · Q2 2026
- Vestal Point Capital, LP 425.00K sh · $14.61M · Q2 2026
- Bollard Group LLC 302.95K sh · $10.41M · Q2 2026
- Ikarian Capital, LLC 205.84K sh · $7.08M · Q2 2026
- SECTORAL ASSET MANAGEMENT INC 71.01K sh · $2.44M · Q2 2026
- Prosight Management, LP 39.73K sh · $1.37M · Q2 2026
- Aldebaran Capital, LLC 36.80K sh · $1.26M · Q2 2026
More on Tetragon Partners GP Ltd
FAQ
How long has Tetragon Partners GP Ltd held TECX?
Tetragon Partners GP Ltd has disclosed TECX holdings in 5 of the last 6 reported quarters, going back to Q1 2025.
What is Tetragon Partners GP Ltd's current position in TECX?
As of Q2 2026, Tetragon Partners GP Ltd holds 46.52K shares of TECX (TECTONIC THERAPEUTIC INC), valued at $1.60M, representing 0.26% of its reported portfolio and ranking #33.
Has Tetragon Partners GP Ltd been buying or selling TECX?
In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in TECX. The position peaked in Q2 2025 at 228.83K shares.
Which other funds hold TECX?
Other major institutional holders of TECX include TCG Crossover Management, LLC, First Light Asset Management, LLC, 5AM Venture Management, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.